系统生物学方法用于药物重用
Juveriya Israr1, Shabroz Alam2, Ajay Kumar3
1Institute of Biosciences and Technology, Shri Ramswaroop Memorial University, Lucknow-Deva Road, Barabanki, Uttar Pradesh, India; Department of Biotechnology Era University, Lucknow, Uttar Pradesh, India.
概括
药物再利用为现有药物找出了新的用途,节省了开发中的数百万美元. 系统生物学通过分析安全有效候选人的数据来加速这一过程.
科学领域:
- 药理学 药理学是指药理学的学科.
- 计算生物学 计算生物学
- 药物发现 药物发现 药物发现
背景情况:
- 药物重新定位提供了一个成本效益高的替代方案,而不是新的药物开发.
- 已知药物具有已知的安全性和药理动力学特征,降低了临床试验风险.
- 显著的成本节约,估计每种重新使用药物3亿美元,推动了对这一策略的兴趣.
研究的目的:
- 探索系统生物学方法在药物重用中的应用.
- 确定用于发现现有药物的新疗法应用的计算技术.
- 利用现有的药物数据,有效识别具有有利安全性概况的候选药物.
主要方法:
- 利用系统生物学方法,包括签名匹配和基于网络的策略.
- 采用计算技术来分析先前存在的与毒品有关的数据和数据库.
- 专注于识别具有最小或可接受的患者副作用的重新用途药物.
主要成果:
- 系统生物学有助于识别可行的药物重定向候选者.
- 计算方法使大数据集的分析能够用于潜在的药物重新定位.
- 该战略优先考虑具有已确定的安全性和药理动力学特性的药物.
结论:
- 系统生物学显著加快了药物重用发现过程.
- 计算方法为基于结构的药物设计提供了新的见解.
- 通过系统生物学增强的药物重新用途,为高效的治疗创新提供了一个有希望的途径.
更多相关视频
相关概念视频
Structure-Activity Relationships and Drug Design
699
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
699
Drug Discovery: Overview
7.8K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.8K
Drug Biotransformation: Overview
2.4K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
2.4K
Model Approaches for Pharmacokinetic Data: Physiological Models
41
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
41
Principles of Drug Action
6.0K
Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
6.0K
Pharmacokinetic Models: Comparison and Selection Criterion
69
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
69


